Immunology and Microbiology
TRAIL
100%
P53
72%
Adenoviridae
45%
Cancer Cell Line
18%
Cancer Cell
9%
Caspase
9%
Cell Viability
9%
Functional Status
9%
Resistant Cell Line
9%
Multiplicity of Infection
9%
Gene
9%
Cells
9%
Radiation
9%
Biochemistry, Genetics and Molecular Biology
TRAIL
100%
P53
72%
Adenoviridae
45%
Clinical Trial
27%
Cancer Cell
9%
Nested Gene
9%
Functional Status
9%
Caspase
9%
Immunocytochemistry
9%
Cell Viability
9%
Radiation
9%
Medicine and Dentistry
Protein P53
72%
Adenoviridae
45%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
27%
Malignant Neoplasm
18%
Cancer Cell Line
18%
Cell Line
18%
Ligand
9%
Immunocytochemistry
9%
Cancer Cell
9%
Combination Therapy
9%
Functional Status
9%
Anticarcinogen
9%
Infection
9%
Cell Viability
9%
Caspase
9%
Resistant Cell Line
9%
Gene
9%
Cells
9%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
72%
Adenoviridae
45%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
27%
Malignant Neoplasm
18%
Chemotherapy
18%
Radiation
18%
Ligand
9%
Anticarcinogen
9%
Infection
9%
Functional Status
9%
Caspase
9%
Neuroscience
P53
72%
Cell Line
36%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
27%
Polymorphism
9%
Cell Viability
9%
Ligand
9%
Chemotherapy
9%
Caspase
9%
Gene
9%